Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up of Patients with Aplastic Anemia Enrolled in Phase 2/3 Trials of Immunosuppressive Therapy Plus Romiplostim As a First-Line Treatment: Two-Year Interim Analysis

Blood (2024) 144 (Supplement 1): 1310.

https://doi.org/10.1182/blood-2024-193925

Published: 2024

Journal Articles

Efficacy and Safety of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Japanese Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 Monumental-1 Study

Shigeki Ito, Yoshiaki Kuroda, Kazutaka Sunami, Kosei Matsue, Kazunori Imada, Hideto Tamura, Mikihiro Takamoto, Hiroshi Yamazaki, Ei Fujikawa, Lixia Pei, Tara J Masterson, Michela Campagna, Bonnie W Lau, Yasushi Takamatsu

Blood (2024) 144 (Supplement 1): 7011.

https://doi.org/10.1182/blood-2024-199663

Published: 2024

Journal Articles

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Blood (2023) 142 (Supplement 1): 4982.

https://doi.org/10.1182/blood-2023-185474

Published: 2023

Journal Articles

Post Hoc Analysis of a Phase 2/3 Study in Japanese Patients with iTTP Treated with Caplacizumab

Kazunori Imada, Yoshitaka Miyakawa, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Yasuhiro Hashimoto, Masashi Nishimi, Sayaka Tahara, Masanori Matsumoto

Blood (2023) 142 (Supplement 1): 5428.

https://doi.org/10.1182/blood-2023-180796

Published: 2023

Journal Articles

Prognostic Impact of Chromosomal Abnormalities in TP53 -Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Blood (2023) 142 (Supplement 1): 4328.

https://doi.org/10.1182/blood-2023-180291

Published: 2023

Journal Articles

The Efficacy and Safety of Caplacizumab in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): An Open-Label, Phase 2/3 Study

Yoshitaka Miyakawa, Kazunori Imada, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Akihito Yonezawa, Shigeki Fujitani, Hiroshi Handa, Tadashi Matsushita, Hidesaku Asakura, Kenji Nishio, Kodai Suzuki, Yasuhiro Hashimoto, Shinobu Ohshima, Sayaka Tahara, Tomoyuki Tanaka, Masanori Matsumoto

Blood (2021) 138 (Supplement 1): 1009.

https://doi.org/10.1182/blood-2021-148427

Published: 2021

Journal Articles

Single Cord Blood Transplantation Versus HLA-Haploidentical Related Donor Transplantation Using Post-Transplant Cyclophosphamide in Patients with Hematological Malignancies

Blood (2021) 138 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2021-149403

Published: 2021

Journal Articles

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Takafumi Kimura, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Ken Ishiyama

Blood (2021) 138 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2021-144689

Published: 2021

Journal Articles

Risk Factors and the Therapeutic Efficacy for Thrombotic Microangiopathy in Patients after Allogeneic Hematopoietic Stem Cell Transplantation - Results of the Multicenter Retrospective Cohort Study

Hiroharu Imoto, Hiroyuki Matsui, MD, Yasuyuki Arai, MD PhD, Tadakazu Kondo, MD PhD, Yasunori Ueda, MD PhD, Kazunori Imada, MD PhD, Takashi Akasaka, MD PhD, Akihito Yonezawa, MD PhD, Kazuhiro Yago, MD PhD, Takayuki Ishikawa, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 4554.

https://doi.org/10.1182/blood-2019-123252

Published: 2019

Journal Articles

Establishment of a Predictive Model of GvHD-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm

Blood (2019) 134 (Supplement_1): 3337.

https://doi.org/10.1182/blood-2019-123241

Published: 2019

Journal Articles

Integrated Analysis of Copy-Number Alterations and Gene Mutations in 2,000 Patients with Myeloid Neoplasms

Ryunosuke Saiki, Yusuke Shiozawa, MD PhD, Tetsuichi Yoshizato, MD PhD, Yasuhito Nannya, MD PhD, June Takeda, MD, Kenichi Yoshida, MD PhD, Yuichi Shiraishi, PhD, Hiroko Tanaka, BA, Kenichi Chiba, PhD, Yoshiko Atsuta, MD PhD, Makoto Onizuka, MD PhD, Hidehiro Itonaga, MD PhD, Masashi Sanada, MD, Yoshinobu Kanda, MD PhD, Bartlomiej Przychodzen, Mikkael A. Sekeres, MD MS, Kathryn Guinta, Yogenthiran Saunthararajah, MD, Lee-Yung Shih, MD, Shuichi Miyawaki, MD PhD, Tsuyoshi Nakamaki, MD PhD, Masataka Taguchi, Shigeo Fuji, MD PhD, Nana Sasaki, MD, Nobuhiko Uoshima, MD PhD, Yasunori Ueda, MD PhD, Yasushi Miyazaki, MD PhD, Kensuke Usuki, MD PhD, Kazunori Imada, MD PhD, Akifumi Takaori-Kondo, MD PhD, Shigeru Chiba, MD PhD, Senji Kasahara, MD PhD, Toru Kiguchi, MD PhD, Hisashi Tsurumi, MD PhD, Luca Malcovati, MD, Mario Cazzola, MD, Takayuki Ishikawa, MD PhD, Satoru Miyano, PhD, Jaroslaw P. Maciejewski, MD PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD

Blood (2019) 134 (Supplement_1): 4216.

https://doi.org/10.1182/blood-2019-132174

Published: 2019

Journal Articles

Phase II Trial of Bortezomib-Based Induction, Autologous Stem Cell Transplantation, Bortezomib-Based Consolidation, and Bortezomib Maintenance in Newly Diagnosed Multiple Myeloma in Japan

Blood (2018) 132 (Supplement 1): 3305.

https://doi.org/10.1182/blood-2018-99-113816

Published: 2018

Journal Articles

Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

Blood (2017) 130 (9): 1114–1124.

https://doi.org/10.1182/blood-2016-09-741983

Published: 2017

Includes: Supplemental data

Journal Articles

Donor Cell-Derived Hematologic Malignancy: A Survey of Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation

Motohiro Kato, MD PhD, Takuya Yamashita, MD PhD, Ritsuro Suzuki, MD PhD, Kimikazu Matsumoto, MD PhD, Hisakazu Nishimori, Satoshi Takahashi, MD, Koji Iwato, MD, Chiaki Nakaseko, MD PhD, Tadakazu Kondo, MD, Kazunori Imada, Fumihiko Kimura, MD, Tatsuo Ichinohe, MDPhD, Yoshiko Hashii, MD PhD, Koji Kato, MD PhD, Yoshiko Atsuta, MDPhD, Shuichi Taniguchi, MD PhD, Takahiro Fukuda, MD

Blood (2015) 126 (23): 859.

https://doi.org/10.1182/blood.V126.23.859.859

Published: 2015

Journal Articles

Investigator-Initiated Phase 2 Trial of Rituximab in Adult Japanese Patients with Treatment-Resistant Acquired Thrombotic Thrombocytopenic Purpura

Yoshitaka Miyakawa, Kazunori Imada, Tatsuo Ichinohe, MDPhD, Yusuke Yamane, MD, Kenji Nishio, Takayuki Abe, Yoshihiro Fujimura, MDPhD, Yasunori Ueda, MD, PhD, Masanori Matsumoto, MD PhD, Shinichiro Okamoto

Blood (2015) 126 (23): 4645.

https://doi.org/10.1182/blood.V126.23.4645.4645

Published: 2015

Journal Articles

Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue

Shin-ichiro Kagami, Hiroshi Nakajima, Kotaro Kumano, Kotaro Suzuki, Akira Suto, Kazunori Imada, Helen W. Davey, Yasushi Saito, Kiyoshi Takatsu, Warren J. Leonard, Itsuo Iwamoto

Blood (2000) 95 (4): 1370–1377.

https://doi.org/10.1182/blood.V95.4.1370.004k29_1370_1377

Published: 2000

Journal Articles

Restoration of Lymphoid Populations in a Murine Model of X-Linked Severe Combined Immunodeficiency by a Gene-Therapy Approach

Mindy Lo, Michael L. Bloom, Kazunori Imada, Maria Berg, Julie M. Bollenbacher, Eda T. Bloom, Brian L. Kelsall, Warren J. Leonard

Blood (1999) 94 (9): 3027–3036.

https://doi.org/10.1182/blood.V94.9.3027

Published: 1999

Journal Articles

Parathyroid Hormone-Related Protein-Induced Hypercalcemia in SCID Mice Engrafted With Adult T-Cell Leukemia Cells

Akifumi Takaori-Kondo, Kazunori Imada, Itsuo Yamamoto, Akane Kunitomi, Yasuharu Numata, Hitoshi Sawada, Takashi Uchiyama

Blood (1998) 91 (12): 4747–4751.

https://doi.org/10.1182/blood.V91.12.4747

Published: 1998

Journal Articles

OX40 Expressed on Fresh Leukemic Cells From Adult T-Cell Leukemia Patients Mediates Cell Adhesion to Vascular Endothelial Cells: Implication for the Possible Involvement of OX40 in Leukemic Cell Infiltration

Akihiro Imura, Toshiyuki Hori, Kazunori Imada, Shin Kawamata, Yuetsu Tanaka, Sadao Imamura, Takashi Uchiyama

Blood (1997) 89 (8): 2951–2958.

https://doi.org/10.1182/blood.V89.8.2951

Published: 1997

NARROW

Long-Term Follow-up of Patients with Aplastic Anemia Enrolled in Phase 2/3 Trials of Immunosuppressive Therapy Plus Romiplostim As a First-Line Treatment: Two-Year Interim Analysis

Efficacy and Safety of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Japanese Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 Monumental-1 Study

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Post Hoc Analysis of a Phase 2/3 Study in Japanese Patients with iTTP Treated with Caplacizumab

Prognostic Impact of Chromosomal Abnormalities in TP53 -Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

The Efficacy and Safety of Caplacizumab in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): An Open-Label, Phase 2/3 Study

Single Cord Blood Transplantation Versus HLA-Haploidentical Related Donor Transplantation Using Post-Transplant Cyclophosphamide in Patients with Hematological Malignancies

Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Risk Factors and the Therapeutic Efficacy for Thrombotic Microangiopathy in Patients after Allogeneic Hematopoietic Stem Cell Transplantation - Results of the Multicenter Retrospective Cohort Study

Establishment of a Predictive Model of GvHD-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm

Integrated Analysis of Copy-Number Alterations and Gene Mutations in 2,000 Patients with Myeloid Neoplasms

Phase II Trial of Bortezomib-Based Induction, Autologous Stem Cell Transplantation, Bortezomib-Based Consolidation, and Bortezomib Maintenance in Newly Diagnosed Multiple Myeloma in Japan

Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

Donor Cell-Derived Hematologic Malignancy: A Survey of Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation

Investigator-Initiated Phase 2 Trial of Rituximab in Adult Japanese Patients with Treatment-Resistant Acquired Thrombotic Thrombocytopenic Purpura

Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue

Restoration of Lymphoid Populations in a Murine Model of X-Linked Severe Combined Immunodeficiency by a Gene-Therapy Approach

Parathyroid Hormone-Related Protein-Induced Hypercalcemia in SCID Mice Engrafted With Adult T-Cell Leukemia Cells

OX40 Expressed on Fresh Leukemic Cells From Adult T-Cell Leukemia Patients Mediates Cell Adhesion to Vascular Endothelial Cells: Implication for the Possible Involvement of OX40 in Leukemic Cell Infiltration

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only